Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Greenwich LifeSciences, Inc. (GLSI) had Stock-Based Compensation of $7.25M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-8.04M |
|
-- |
|
-- |
|
$8.08M |
|
$-8.08M |
|
$0.04M |
|
$-8.04M |
|
$-8.04M |
|
$-8.04M |
|
$-8.04M |
|
$-8.04M |
|
$-8.04M |
|
$-8.08M |
|
$-8.08M |
|
13.02M |
|
13.02M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$4.09M |
|
-- |
|
$0.00M |
|
$4.09M |
|
$1.56M |
|
-- |
|
-- |
|
$1.56M |
|
$2.53M |
|
$2.53M |
|
$2.53M |
|
13.15M |
|
| Cash Flow Statement Financials | |
$-7.27M |
|
-- |
|
$4.37M |
|
$6.99M |
|
$4.09M |
|
$-2.90M |
|
|
Stock-Based Compensation |
$7.25M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-317.29% |
|
-317.51% |
|
-196.40% |
|
-317.29% |
|
$0.19 |
|
$-0.56 |
|
$-0.56 |
|